Avior Wealth Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-170
| Closed | -$13.3K | – | 1418 |
|
|
2024
Q4 | $13.3K | Buy |
170
+9
| +6% | +$703 | ﹤0.01% | 1530 |
|
|
2024
Q3 | $12.9K | Buy |
161
+109
| +210% | +$8.76K | ﹤0.01% | 1477 |
|
|
2024
Q2 | $4.3K | Sell |
52
-10
| -16% | -$827 | ﹤0.01% | 1767 |
|
|
2024
Q1 | $5.29K | Buy |
62
+36
| +138% | +$3.07K | ﹤0.01% | 2066 |
|
|
2023
Q4 | $2.22K | Sell |
26
-17
| -40% | -$1.45K | ﹤0.01% | 1291 |
|
|
2023
Q3 | $3.85K | Hold |
43
| – | – | ﹤0.01% | 1266 |
|
|
2023
Q2 | $3.66K | Buy |
+43
| New | +$3.66K | ﹤0.01% | 1261 |
|
|
2022
Q1 | – | Sell |
-5,734
| Closed | -$304K | – | 1163 |
|
|
2021
Q4 | $304K | Hold |
5,734
| – | – | 0.03% | 389 |
|
|
2021
Q3 | $404K | Buy |
+5,734
| New | +$404K | 0.03% | 348 |
|
|
2020
Q2 | – | Sell |
-1,830
| Closed | -$182K | – | 939 |
|
|
2020
Q1 | $182K | Sell |
1,830
-1,530
| -46% | -$152K | 0.04% | 356 |
|
|
2019
Q4 | $386K | Buy |
3,360
+840
| +33% | +$96.5K | 0.06% | 268 |
|
|
2019
Q3 | $317K | Hold |
2,520
| – | – | 0.06% | 287 |
|
|
2019
Q2 | $303K | Sell |
2,520
-280
| -10% | -$33.7K | 0.05% | 294 |
|
|
2019
Q1 | $244K | Sell |
2,800
-696
| -20% | -$60.7K | 0.05% | 315 |
|
|
2018
Q4 | $349K | Buy |
3,496
+1,058
| +43% | +$106K | 0.08% | 221 |
|
|
2018
Q3 | $279K | Buy |
2,438
+548
| +29% | +$62.7K | 0.06% | 274 |
|
|
2018
Q2 | $169K | Sell |
1,890
-1,412
| -43% | -$126K | 0.04% | 365 |
|
|
2018
Q1 | $242K | Sell |
3,302
-1,155
| -26% | -$84.6K | 0.06% | 268 |
|
|
2017
Q4 | $259K | Buy |
+4,457
| New | +$259K | 0.06% | 273 |
|